Krishna Singh, M.D. for UC Davis Health

Krishna Singh, M.D.

Assistant Clinical Professor

To see if Krishna Singh is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Maternal-Fetal Medicine



Locations and Contact

Lawrence J. Ellison Ambulatory Care Center

Obstetrics and Gynecology Clinic
4860 Y St.
Sacramento, CA 95817

Get Directions

Phone: 916-734-6900

Additional Numbers

Clinic Phone


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Singh believes in looking at the complete picture of a patient including detailing various aspects of personal past history and linking this with family history and current clinical findings to direct a specified care plan.

Clinical Interests

Dr. Krishna Singh is triple board certified in Obstetrics and Gynecology, Maternal Fetal Medicine, and Medical Genetics and Genomics. She has expertise in diagnostic evaluation and advanced molecular testing of adults and fetuses with rare genetic conditions. Dr. Singh guides in reproductive planning and care of pregnancies among couples with personal or family history of heritable disease, as well as interpretation of fetal ultrasound and evaluation of prior fetal or neonatal loss.

Research/Academic Interests

Dr. Singh's research interests include identifying fetal presentations of rare genetic disorders and use of prenatal screening tests to predict various obstetrical outcomes.


Fetal Care and Treatment Center
Maternal Fetal Medicine

Medical School

M.D., St. George’s University School of Medicine, Grenada, West Indies 2004


Obstetrics and Gynecology, Albany Medical Center, Albany NY 2004-2005


Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis TN 2005-2008


Maternal Fetal Medicine, Cedars-Sinai Medical Center, Los Angeles CA 2010-2013


Clinical Genetics, Intercampus Medical Genetics Program at the UCLA, Los Angeles CA 2008-2010

Cedars-Sinai Fellows Award for Excellence in Research, 2013

Singh K, Williams J 3rd, Brown J, Wang ET, Lee B, Gonzalez TL, Cui J, Goodarzi MO, Pisarska MD. Up-regulation of microRNA-202-3p in first trimester placenta of pregnancies destined to develop severe preeclampsia, a pilot study. Pregnancy Hypertens. 2017 Oct;10:7-9. doi:10.1016/j.preghy.2017.04.002. Epub 2017 May 8. PMID:29153693.

Singh K, Moore S, Sandoval M, Balzer B, Frishberg D, Lewin S, Schreck R, Raffel L. Congenital malignant melanoma: a case report with cytogenetic studies. Am J Dermatopathol. 2013 Dec;35(8):e135-8. doi:10.1097/DAD.0b013e318284a679. PMID:23907318.

Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol. 2013 Apr;208(4):329.e1-6. doi:10.1016/j.ajog.2013.01.026. Epub 2013 Jan 17. PMID:23333547.

ElNaggar AC, Patil AS, Singh K, Reed ME. Neuroendocrine carcinoma of the vagina in pregnancy. Obstet Gynecol. 2012 Feb;119(2 Pt 2):445-447. doi:10.1097/AOG.0b013e318236ffcd. PMID:22270433.

Rajendra K, Bringman JJ, Ward J, Phillips OP. Who should be tested for fragile X carriership? A review of 1 center's pedigrees. Am J Obstet Gynecol. 2008 May;198(5):e51-3. doi:10.1016/j.ajog.2007.12.023. Epub 2008 Mar 20. PMID:18358452.